Product Details
Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 mg - 150 mg - 200 mg - 10 mg Tablet Bottle 30 Tablets
Manufacturer: GILEAD SCIENCES
MFG#: 61958-1901-01
NDC: 61958-1901-01
PID: 350446
Additional Information
| Product Name | Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 Mg - 150 Mg - 200 Mg - 10 Mg Tablet Bottle 30 Tablets |
| Application | HIV Integrase Inhibitor |
| Generic Drug Name | Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide |
| Mechanism of Action | Elvitegravir inhibits integrase, Cobicistat enhances drug levels, Emtricitabine and Tenofovir inhibit reverse transcription |
| Dosage Form | Tablet |
| Strength | 150 mg Elvitegravir, 150 mg Cobicistat, 200 mg Emtricitabine, 10 mg Tenofovir Alafenamide |
| Dosing Frequency | Once daily with food |
| Common Side Effects | Diarrhea, headache, nausea, fatigue, upper respiratory tract infections |
| Serious Adverse Effects | Kidney dysfunction, liver toxicity, lactic acidosis, bone mineral density loss |
| Container Type | Bottle |
| Quantity | 30 Tablets |
| Indications | HIV-1 infection treatment in adults and pediatric patients (=35 kg) |
Description
Genvoya® is a fixed-dose combination tablet containing elvitegravir (150 mg), cobicistat (150 mg), emtricitabine (200 mg), and tenofovir alafenamide (10 mg). Genvoya® can be used as a complete regimen for treatment-naïve patients or as a replacement therapy for patients who are virologically suppressed on a stable antiretroviral (ARV) regimen for at least 6 months, with no history of treatment failure or resistance to any of the components.
Each tablet is green, capsule-shaped, and film-coated, with "GSI" debossed on one side and "510" on the other. Genvoya® works by combining the actions of four antiretroviral agents: elvitegravir inhibits the integrase enzyme, cobicistat acts as a pharmacokinetic enhancer to boost elvitegravir levels, while emtricitabine and tenofovir alafenamide are nucleoside reverse transcriptase inhibitors (NRTIs) that prevent viral replication.
The recommended dosage of Genvoya® is one tablet taken once daily with food. It is important to adhere to the prescribed regimen to maintain viral suppression and prevent the development of resistance. Regular monitoring of kidney function and liver enzymes is recommended, as adverse effects may occur.
Frequently Asked Questions (FAQs)
The cost of Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 mg - 150 mg - 200 mg - 10 mg Tablet Bottle 30 Tablets is $available for registerd members only
Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 mg - 150 mg - 200 mg - 10 mg Tablet Bottle 30 Tablets is manufactured by GILEAD SCIENCES.
You can purchase Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 mg - 150 mg - 200 mg - 10 mg Tablet Bottle 30 Tablets on our website at https://supplies.pipelinemedical.com/product/detail/genvoya-elvitegravir-cobicistat-emtricitabine-and-tenofovir-alafenamide-tablet-350446